AGP Picks
View all

Global Finance Herald: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Global Finance Herald.

Press releases published on September 30, 2026

Elite Property Innovations Highlights Hearth Financial Option for Westminster-Area Kitchen and Bathroom Remodels
ARACORE Announces Strategic Partnership with Stable
Robotimize Highlights KidGo Exoskeleton at CPAS Symposium 2026 in Singapore
Pulse International AG Takes Its Design-Led Spatial Practice Global
Qiwang Peanuts Expands Globally, Powers Hong Kong Retail Launch with Lekeos Cloud POS
HIVEX Enables 48 Million Binance Pay Users to Shop at PayPay Merchants Across Japan
Link Publishers Heads to brightonSEO 2026 to Discuss the Future of Search Visibility
Ocugen to Participate in Upcoming Scientific Conferences
R1 Therapeutics expands Series A to $80.5 million to advance global Phase 2b program in hyperphosphatemia
More Than 1,600 Participants Anchor Calroy Health Sciences' Joint Formulation Research
Hatteras Venture Partners Names Sir Andrew Witty as Chairman and Ned Sharpless, M.D., as Managing Director of Hatteras Discovery Innovation, Expanding Proven Investment Strategies
GlobalFoundries Announces Conference Call to Review Third Quarter 2026 Financial Results
UNISYNC Announces Normal Course Issuer Bid and Automatic Securities Purchase Plan
AI Visibility for Industrial Automation Companies Averages 4% Across the Top 100 Vendors, Benchmark Finds
FactSet Reports Results for Fourth Quarter and Fiscal 2026
Adlai Nortye Appoints Christopher Liu, PharmD, as Head of Investor Relations and Public Relations
10 Barrel Expands Salty Sips RTD Portfolio with New Blackberry Refresher
Sono-Tek Announces Record $7.19 Million in Orders from Advanced Clean Energy Sector Customer
Kailera Therapeutics Announces Completion of Enrollment in KaiNETIC Global Phase 3 Clinical Program of GLP-1/GIP Receptor Dual Agonist Ribupatide Injection
Jade Biosciences Announces Preclinical Data Characterizing JADE301, a Potentially Best-in-Class, Half-Life-Extended Anti-IFN-β Monoclonal Antibody in Development for Dermatomyositis, at EADV 2026

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Global Finance Herald

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.